Catherine M. Bollard, MD, FRACP, FRCPA
Bosworth Chair for Cancer Biology
Professor of Pediatrics and of Microbiology, Immunology and Tropical Medicine
Director,, Center for Cancer and Immunology Research
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Children's National Hospital and The George Washington University, Maryland
Disclosure: Cabaletta Bio : Board Member (Status: Ongoing), Other Financial or Material Support (Status: Ongoing), Stock options (Status: Ongoing); Catamaran Bio : Co-Founder / SAB / Stock Options (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Mana Therapeutics : Co-founder / SAB / Stock Options (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Neximmune : Other Financial or Material Support (Status: Ongoing), Stock options (Status: Ongoing); Repertoire Immune Medicines (formerly Torque Therapeutics) : Other Financial or Material Support (Status: Ongoing), Stock options (Status: Ongoing)
